AI in Action
LMRLarge Molecule Research · Driven by data & AI

Molecules by design.

70% fewer molecules requiring experimental characterization.

BioAIM helps scientists identify the right biologic candidates earlier by combining predictive AI, computational biology, and experimental data to support smarter discovery decisions.

From evaluating developability and manufacturability to focusing laboratory efforts on the most promising molecules, BioAIM empowers researchers to design better biologics with greater confidence.

01Challenge02AI Technology03Applied Today04Real-World Example05Impact
05 · Impact

Better biologic therapies to patients, faster.

By helping scientists identify the right biologic candidates earlier, BioAIM strengthens decision-making, improves productivity, and helps deliver better biologic therapies to patients faster.

Accelerate biologics discovery
Improve confidence in candidate selection
Focus experimental resources on the most promising candidates
Increase productivity across research
Deliver better therapies to patients
Story · 05 Impact
01Accelerate biologics discovery
70%fewer molecules requiring experimental characterization
←→ to move between stages · Stage 5 of 5 · LMR
Smarter decisions.Better biologics.Better medicines.

Helping scientists identify the right biologic candidates earlier and with greater confidence.

LMR original poster
Original poster · click anywhere or press Esc to close
Next program: TDSB →